Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Polypid Ltd (PYPD)

Polypid Ltd (PYPD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.74 +0.02 (+0.74%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.74 unch (unch) 15:59 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.66
Day High
2.75
Open 2.66
Previous Close 2.72 2.72
Volume 32,300 32,300
Avg Vol 16,340 16,340
Stochastic %K 9.81% 9.81%
Weighted Alpha -44.98 -44.98
5-Day Change -0.07 (-2.49%) -0.07 (-2.49%)
52-Week Range 2.37 - 5.09 2.37 - 5.09
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,923
  • Shares Outstanding, K 10,191
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,020 K
  • EBIT $ -28 M
  • EBITDA $ -26 M
  • 60-Month Beta 1.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.74
  • Number of Estimates 1
  • High Estimate -0.74
  • Low Estimate -0.74
  • Prior Year -1.37
  • Growth Rate Est. (year over year) +45.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.66 +2.92%
on 03/28/25
Period Open: 3.23
3.26 -15.95%
on 03/03/25
-0.49 (-15.17%)
since 02/28/25
3-Month
2.62 +4.58%
on 12/30/24
Period Open: 2.89
3.47 -21.15%
on 01/27/25
-0.15 (-5.19%)
since 12/27/24
52-Week
2.37 +15.61%
on 12/16/24
Period Open: 4.60
5.09 -46.17%
on 05/01/24
-1.86 (-40.43%)
since 03/28/24

Most Recent Stories

More News
Q1 Virtual Investor Summit: On-Demand Presentations Now Live

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / The Investor Summit is excited to announce that presentations from Q1 Investor Summit are now available for on-demand viewing. Attendees and investors...

SNANF : 0.1900 (unch)
BRNS : 1.0500 (unch)
FEMY : 1.2900 (-3.37%)
PERF : 1.6900 (+0.60%)
DRTS : 2.56 (-3.76%)
GIFT : 2.17 (+3.33%)
ROYIF : 0.0202 (-51.21%)
ZCAR : 4.13 (-14.42%)
CLNN : 3.22 (+1.26%)
MIND : 5.89 (-4.07%)
PYPD : 2.74 (+0.74%)
TOVX : 1.1400 (-5.79%)
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025

NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial...

PYPD : 2.74 (+0.74%)
PolyPid Ltd. Announces Research Collaboration with ImmunoGenesis to Enhance Immunotherapy for Solid Tumors

PolyPid collaborates with ImmunoGenesis to enhance solid tumor treatment using innovative drug delivery technologies.Quiver AI SummaryPolyPid Ltd. has announced a collaboration with ImmunoGenesis, Inc....

PYPD : 2.74 (+0.74%)
PolyPid Ltd. Faces Nasdaq Non-Compliance Notification Due to Stockholders' Equity Shortfall

PolyPid Ltd. faces Nasdaq non-compliance but has potential funding options to regain stockholder equity requirements.Quiver AI SummaryPolyPid Ltd., a late-stage biopharma company focused on improving surgical...

PYPD : 2.74 (+0.74%)
PolyPid Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Signed Exclusive Licensing Agreement for Commercialization of D-PLEX100 in Europe for Potentially Over $110 Million in Upfront and Milestone Payments, Plus...

PYPD : 2.74 (+0.74%)
PolyPid to Report Second Quarter 2022 Financial Results and Operational Highlights on August 10, 2022

PETACH TIKVA, Israel, July 27, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company...

PYPD : 2.74 (+0.74%)
PolyPid Announces Presentation of Phase 2 D-PLEX₁₀₀ Clinical Data at the Midwest Surgical Association 2022 Annual Meeting

Efficacy Data of D-PLEX100 in the Prevention of Post-Abdominal Surgery Incisional Infection in High-Risk Patients will be Presented During a Podium...

PYPD : 2.74 (+0.74%)
PolyPid Hosting Key Opinion Leader Webinar on Managing the Cost of Surgical Site Infections

PETACH TIKVA, Israel, June 15, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming...

PYPD : 2.74 (+0.74%)
PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ at the Minimum Number of Patients Targeted Following Unblinded Interim Efficacy Analysis

• Enrollment of 950 Patients, the Minimum Number of Patients Targeted for the SHIELD I Study, Expected Within Days • Top-line Results Expected by End of...

PYPD : 2.74 (+0.74%)
PolyPid Provides Corporate Update and Reports First Quarter 2022 Financial Results

•  Planned Unblinded Interim Analysis of Phase 3 SHIELD I Trial of D-PLEX100 in Abdominal Soft Tissue Surgery Expected to Occur Imminently •  Recruitment...

PYPD : 2.74 (+0.74%)

Business Summary

PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

See More

Key Turning Points

3rd Resistance Point 2.86
2nd Resistance Point 2.81
1st Resistance Point 2.77
Last Price 2.74
1st Support Level 2.68
2nd Support Level 2.63
3rd Support Level 2.60

See More

52-Week High 5.09
Fibonacci 61.8% 4.05
Fibonacci 50% 3.73
Fibonacci 38.2% 3.41
Last Price 2.74
52-Week Low 2.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies